ASBPAspire Biopharma Holdings, Inc.vs its industry peers
A metric-by-metric comparison of Aspire Biopharma Holdings, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASBPThis | $12M#5 | 0.0x#2 | 1.0x#2 | 1888.3x#5 | — | -1768.9%#9 | -312016.9%#5 | -208.2%#4 | — | — | -98.4%#3 | — |
| HIND | $14M#1 | 0.0x#1 | 5.6x#5 | 44.6x#3 | 24.4%#2 | -609.0%#8 | -3269.4%#3 | -405.7%#6 | -226.2%#2 | — | -72.9%#2 | — |
| LSTA | $14M#2 | — | 1.7x#4 | 81.1x#4 | -83.0%#4 | 17.0%#2 | -10711.2%#4 | -201.2%#3 | — | 3#1 | — | — |
| ADIL | $14M#3 | — | — | — | — | 39.5%#1 | — | — | — | — | -40.9%#1 | — |
| AEON | $13M#4 | — | — | — | — | -193.4%#6 | — | — | — | — | — | — |
| DARE | $11M#6 | — | — | 10.9x#1 | 10429.4%#1 | -230.9%#7 | -1315.5%#2 | — | — | — | — | — |
| LIPO | $11M#7 | — | 7.1x#6 | 19.8x#2 | 19.3%#3 | -8.6%#4 | -947.2%#1 | -337.2%#5 | — | — | — | — |
| AZTR | $11M#8 | 8.7x#4 | 1.4x#3 | — | -100.0%#5 | -22.2%#5 | — | -149.4%#2 | — | — | — | — |
| TOVX | $10M#9 | 0.2x#3 | 0.2x#1 | — | -100.0%#5 | 7.5%#3 | — | -42.1%#1 | -51.4%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice